前收市價 | 33.75 |
開市 | 34.37 |
買盤 | 34.44 x 200 |
賣出價 | 34.51 x 100 |
今日波幅 | 33.67 - 34.56 |
52 週波幅 | 11.46 - 43.21 |
成交量 | |
平均成交量 | 946,413 |
市值 | 1.994B |
Beta 值 (5 年,每月) | 1.64 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -3.61 |
業績公佈日 | 2024年5月03日 - 2024年5月07日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 40.75 |
You can’t say Cathie Wood is afraid to make big bets. The investing guru is more than willing to lay it all on the line for stocks she believes in. Of the top Cathie Wood stocks picked up in 2024, she’s bought $160 million worth of Tesla (NASDAQ:TSLA) for her Ark Invest family of funds even though the electric vehicle maker is down 22% this year. But you have to admire how Wood sticks to her guns. But Tesla isn’t the only big bet she’s making. In fact, the investing star is loading up on a numbe
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2024 Earnings Call Transcript February 2, 2024 Twist Bioscience Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to Twist Bioscience’s Fiscal 2024 First Quarter Financial Results Conference Call. At this time, all participants […]
Genomics is undeniably medicine’s future, and genomics stocks stand to be the next big thing in healthcare as the industry matures. But the crux of the matter is when the industry will mature. Medical advancement lead times, regulatory approval, and expensive R&D combine to make genomics stocks a risky speculative play today while we await the industry’s winner. But betting on the future is inherently a risky move, and not for the week of heart. Just ask Cathie Wood, whose genomics fund, the ARK